No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
Frederic Fasano acts as Chief Executive Officer and co-founder of Alpioner Therapeutics. He is a seasoned pharma and Biotech executive with over 25 years of experience in managing strategic affiliates and specialty pharma companies in different geographies (Canada, Europe, Latin America). Prior to that, he worked for Valeo Pharma as President and COO where he led the rapid growth and transformation of the operations and the consolidation of the financial position through several financing rounds. Before that, he served as President and CEO of Servier Canada, a fully integrated affiliate of Servier Group. During his tenure, he led the portfolio diversification strategy, including multiple in-licensing deals, regulatory filings, and market access negotiations, while strengthening the corporate structure to maximize the affiliate’s growth. Frederic held various leadership positions in Italy, as CEO of Servier Italy and IFB Stroder, in France and Latin America. He sat on the Board of Directors of ILKOS Therapeutics, a biotechnology company founded in partnership with a Venture Capital firm. He also served as Chairman of the Board of Innovative Medicines Canada. He holds a master’s degree in business administration from ESSEC Business School (France) and a Pharm. Degree from Paris-Saclay University (France). He recently earned a certified corporate directorship from McGill – Institute of Corporate Director (Canada).